83 related articles for article (PubMed ID: 2102412)
1. [Immunohistochemical results obtained with bromodeoxy uridine (BUdR) labelled tumors of the head and neck].
Radner H; Kärcher H
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(2):116-21. PubMed ID: 2102412
[TBL] [Abstract][Full Text] [Related]
2. [A review of cell kinetic studies on brain tumors with special reference to anti-bromodeoxyuridine monoclonal antibody method].
Nagashima T; Hoshino T
No Shinkei Geka; 1984 Aug; 12(9):1007-18. PubMed ID: 6390240
[TBL] [Abstract][Full Text] [Related]
3. Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.
Preisler HD; Kotelnikov VM; LaFollette S; Taylor S; Mundle S; Wood N; Coon JS; Hutchinson J; Panje W; Caldarelli DD; Griem K
Clin Cancer Res; 1996 Sep; 2(9):1453-60. PubMed ID: 9816320
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
5. Cell proliferation of human leukemia and solid tumors studied with in vivo bromodeoxyuridine and flow cytometry.
Giordano M; Riccardi A; Danova M; Brugnatelli S; Mazzini G
Cancer Detect Prev; 1991; 15(5):391-6. PubMed ID: 1751950
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometry studies of incorporated bromodeoxyuridine (BUdR) in carcinoma of the oral cavity. A new method].
Kärcher H; McNally NJ; Wilson G; Pfragner R
Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(5):327-30. PubMed ID: 3868460
[No Abstract] [Full Text] [Related]
8. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
Edström S; Cvetkovska E; Westin T; Young C
Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
[TBL] [Abstract][Full Text] [Related]
9. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
[TBL] [Abstract][Full Text] [Related]
10. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
Corvò R; Giaretti W; Margarino G; Danova M; Vitale V
Radiol Med; 1991; 82(1-2):147-52. PubMed ID: 1896568
[TBL] [Abstract][Full Text] [Related]
11. Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer.
Kotelnikov VM; Coon JS; Taylor S; Hutchinson J; Panje W; Caldareill DD; LaFollette S; Preisler HD
Head Neck; 1996; 18(6):522-8. PubMed ID: 8902565
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues.
Kotelnikov V; Cass L; Coon JS; Spaulding D; Preisler HD
Clin Cancer Res; 1997 May; 3(5):669-73. PubMed ID: 9815735
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.
Johnson TS; Williamson KD; Cramer MM; Peters LJ
Cytometry; 1985 Sep; 6(5):461-70. PubMed ID: 4042786
[TBL] [Abstract][Full Text] [Related]
14. Cell kinetics of head and neck cancers.
Kotelnikov VM; Coon JS IV; Haleem A; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Griem K; Preisler HD
Clin Cancer Res; 1995 May; 1(5):527-37. PubMed ID: 9816012
[TBL] [Abstract][Full Text] [Related]
15. Application of in vitro bromodeoxyuridine labeling of oral cancers.
Wato M; Nishikawa T; Fujita A; Nagao Y; Tsujimoto K; Matsuoka K; Horii K; Okano H; Tanaka A
J Osaka Dent Univ; 1993 Oct; 27(2):113-20. PubMed ID: 8182503
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma.
Nieuwenhuis EJ; van der Waal I; Leemans CR; Kummer A; Pijpers R; Castelijns JA; Brakenhoff RH; Snow GB
Head Neck; 2005 Feb; 27(2):150-8. PubMed ID: 15627261
[TBL] [Abstract][Full Text] [Related]
17. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
Maeda T; Hoshino T
No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
[TBL] [Abstract][Full Text] [Related]
18. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma.
Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B
Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in N0 squamous cell carcinoma of the oral cavity and oropharynx.
Hart RD; Nasser JG; Trites JR; Taylor SM; Bullock M; Barnes D
Arch Otolaryngol Head Neck Surg; 2005 Jan; 131(1):34-8. PubMed ID: 15655182
[TBL] [Abstract][Full Text] [Related]
20. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in healthy tissue in the direct vicinity of the first tumor.
Bongers V; Snow GB; de Vries N; Cattan AR; Hall AG; van der Waal I; Braakhuis BJ
Lab Invest; 1995 Oct; 73(4):503-10. PubMed ID: 7474922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
